PubMed, the Internet portal of biomedical and life sciences literature, indexed an interesting article, entitled Guideline “Differentiated thyroid carcinoma” (Ned Tijdschr Geneeskd. 2007 Aug 11;151(32):1777-82). Authors are Links TP, Huysmans DA, Smit JW, et al., from the Universitair Medisch Centrum Groningen, afd. Interne Geneeskunde, subafd. Endocrinologie, Groningen. Differentiated thyroid carcinoma is a rare disease. The Dutch Society of Nuclear Medicine and the Dutch Endocrine Society developed an evidence-based guideline that emphasises not only new scientific developments but also the organisation of care. Thyroid-stimulating hormone (TSH) assessment and fine needle aspiration cytology play a central role in the diagnostic assessment of a patient with a thyroid nodule. Follow-up protocols distinguish between patients with a low risk of thyroid-carcinoma recurrence and those with a non-low risk of recurrence. To access the full abstract of the article, click here.
484
previous post
Treatment of cryopirin-associated periodic syndromes
next post